The New Lipid Guidelines: What Do Primary Care Clinicians Think?

American Journal of Medicine

Volumn 128, Issue 8, 2015, Pages 914.e5-914.e10

  Jamé, Sina ^a   Wittenberg, Eve ^b   Potter, Michael B ^a   Fleischmann, Kirsten E ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AHA ACC guidelines; Cholesterol; Primary care providers

Indexed keywords

ADULT; ARTICLE; ATHEROSCLEROSIS; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; DECISION MAKING; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE SURVEY; HEALTH CARE SYSTEM; HUMAN; INTERNET; MALE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIMARY PREVENTION; PRIORITY JOURNAL; AGED; COMPLICATION; CORONARY ARTERY DISEASE; GENERAL PRACTITIONER; HYPERCHOLESTEROLEMIA; MEDICAL SOCIETY; MIDDLE AGED; UNITED STATES; YOUNG ADULT;

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; AMERICAN HEART ASSOCIATION; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; GUIDELINE ADHERENCE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PHYSICIANS, PRIMARY CARE; PRACTICE GUIDELINES AS TOPIC; PRACTICE PATTERNS, PHYSICIANS'; UNITED STATES; YOUNG ADULT;

EID: 84937817323     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2015.02.013     Document Type: Article

References (16)

1. N.J. Stone, J. Robinson, A.H. Lichtenstein, and et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 129 25 suppl 2 2013 S1 S45 Risk Calculator: http://tools.cardiosource.org/ASCVD-Risk-Estimator/
2. M. Kavousi, M.J. Leening, D. Nanchen, and et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort JAMA 311 14 2014 1416 1423
3. M.J. Pencina, A.M. Navar-Boggan, R.B. D'Agostino, and et al. Application of new cholesterol guidelines to a population-based sample N Engl J Med 370 2014 1422 1431
4. D.M. Lloyd-Jones, D. Goff, and N.J. Stone Statins, risk assessment, and the new American prevention guidelines Lancet 383 9917 2014 600 602
5. J.P. Ioannidis More than a billion people taking statins? Potential implications of the new cardiovascular guidelines JAMA 311 2014 463 464
6. P.M. Ridker, and N.R. Cook Statins: new American guidelines for prevention of cardiovascular disease Lancet 382 2014 1762 1765
7. Kolata G. Bumps in the road to new cholesterol guidelines. The New York Times. 2013, November 26; A17.
8. Kolata G. Risk calculator for cholesterol appears flawed. The New York Times. 2013, November 18; A1.
9. Kolata G. New cholesterol advice startles even some doctors. The New York Times. 2013, November 13; A4.
10. P. Muntner, L.D. Colantonio, M. Cushman, and et al. Validation of the atherosclerotic cardiovascular disease pooled cohort risk equations JAMA 311 2014 1406 1415
11. UCSF Accelerate. San Francisco Bay Area Collaborative Research Network (SF Bay CRN). Available at: http://accelerate.ucsf.edu/community/sfbaycrn. Accessed September 4, 2014.
12. Berry E, Ward T. CV guidelines, sex post-MI, and barriers to heart health: docs weigh in. Medscape. March 2014. Available at: http://www.medscape.com/features/slideshow/heart-health-survey#1. Accessed September 28, 2014.
13. Silverman E. What doctors are saying about those new cholesterol meds. Available at: http://blogs.wsj.com/pharmalot/2014/09/02/what-doctors-are-saying-about-those-new-cholesterol-meds. Accessed September 28, 2014.
14. Hensley S. Mixed feelings about side effects from cholesterol pills. Available at: www.npr.org/blogs/health/2012/08/01/157729714/mixed-picture-on-perceptions-of-cholesterol-pill-side-effects, August 2nd, 2012. Accessed October 10, 2014.
15. M. Fontana, P. Asaria, M. Moraldo, and et al. Patient accessible tool for shared decision making in cardiovascular primary prevention: Balancing longevity benefits against medication disutility Circulation 129 2014 2539 2546
16. S.F. Derose, K. Green, E. Marrett, and et al. Automated outreach to increase primary adherence to cholesterol lowering medications JAMA Intern Med 173 2013 38 43